发明名称 Stabilized pharmaceutical compositions containing a calcium channel blocker
摘要 The present invention provides a pharmaceutical composition containing a calcium channel blocker of the following formula or a pharmacologically acceptable salt thereof and a pharmacologically acceptable alkaline material which is added to an extent such that an aqueous solution or dispersion solution of said pharmaceutical composition containing a calcium channel blocker has a pH of at least 8: [wherein R<SUP>1 </SUP>represents an optionally substituted C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl group, an amino group or a cyano group; R<SUP>2 </SUP>represents an optionally substituted C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl group, a substituted C<SUB>3</SUB>-C<SUB>4 </SUB>alkenyl group, or a substituted 4- to 6-membered cyclic amino group; R<SUP>3 </SUP>represents a substituted phenyl group; R<SUP>4 </SUP>represents an optionally substituted C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxycarbonyl group, a 1,3,2-phosphorinan-2-yl group, or a 5,5-dimethyl-1,3,2-phosphorinan-2-yl group, R<SUP>5 </SUP>represents a C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl group].
申请公布号 US2007142442(A1) 申请公布日期 2007.06.21
申请号 US20070704122 申请日期 2007.02.08
申请人 UBE INDUSTRIES, LTD. 发明人 WAKIYAMA NAOKI;USUI FUSAO;NISHIMURA KENJI
分类号 A61K31/455;A61K9/20;A61K31/4418;A61K31/4422;A61K31/4427;A61K31/443;A61K31/4439;A61K31/444;A61K31/4545;A61K31/496;A61K31/675;A61K47/02;A61P9/12;C07D211/90;C07D401/06;C07F9/6571 主分类号 A61K31/455
代理机构 代理人
主权项
地址